oral poliovirus vaccine (OPV)
GPTKB entity
Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:appointed_by |
gptkb:Person
national immunization days other childhood vaccines |
| gptkbp:associated_with |
gptkb:vaccine
community immunity |
| gptkbp:caused_by |
vaccine-associated paralytic poliomyelitis (VAPP) in rare cases
|
| gptkbp:clinical_trial |
extensively tested
|
| gptkbp:contributed_to |
herd immunity
|
| gptkbp:developed_by |
gptkb:Albert_Bruce_Sabin
|
| gptkbp:dosage_form |
multiple doses required
|
| gptkbp:financial_performance |
stable at room temperature
|
| gptkbp:first_introduced |
gptkb:1961
|
| gptkbp:formulation |
drops
|
| gptkbp:global_presence |
widely used in developing countries
|
| gptkbp:has |
subject of extensive research
|
| gptkbp:healthcare |
significantly reduced polio cases
|
| https://www.w3.org/2000/01/rdf-schema#label |
oral poliovirus vaccine (OPV)
|
| gptkbp:influenced_by |
public health policies
|
| gptkbp:introduced |
many countries during the 1960s
|
| gptkbp:is_available_in |
developing countries
liquid form |
| gptkbp:is_considered |
a key tool in polio eradication efforts
|
| gptkbp:is_effective_against |
high
non-polio enteroviruses wild poliovirus types 1, 2, and 3 |
| gptkbp:is_monitored_by |
post-vaccination surveillance
|
| gptkbp:is_part_of |
national immunization programs
WHO's Expanded Programme on Immunization (EPI) |
| gptkbp:is_used_in |
countries with polio eradication status
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
various pharmaceutical companies
|
| gptkbp:part_of |
gptkb:Global_Polio_Eradication_Initiative
|
| gptkbp:replaced_by |
inactivated poliovirus vaccine (IPV) in some countries
|
| gptkbp:requires |
trained healthcare personnel for administration
cold chain for distribution |
| gptkbp:safety_features |
generally safe
|
| gptkbp:side_effect |
rarely causes mild gastrointestinal symptoms
|
| gptkbp:status |
polio eradication efforts
|
| gptkbp:storage |
requires refrigeration
|
| gptkbp:successor |
inactivated poliovirus vaccine (IPV) in some regions
|
| gptkbp:suitable_for |
gptkb:World_Health_Organization
immunocompromised individuals children under 5 years old |
| gptkbp:targets |
gptkb:poliomyelitis
|
| gptkbp:type |
live attenuated vaccine
|
| gptkbp:used_in |
mass immunization campaigns
routine immunization schedules |
| gptkbp:bfsParent |
gptkb:poliomyelitis
|
| gptkbp:bfsLayer |
3
|